M6G, A New Morphine Derivative For Post-Operative Pain Relief

 

Key Data:

Drug (brand/generic)
Morphine –6-Glucuronide (M6G)
Company/licensee
CeNeS Pharmaceuticals
Therapy class
Opioid
Product description
Morphine derivative
Current indication
Severe post-operative pain
Market sector
CNS – pain
Development status
Phase III



Home
New On This Site
Products & Services
Company A-Z
Industry Projects
White Papers
Jobs & Careers
Press Releases
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area


RSS What is RSS
For every phase of your drug development